BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Business

  Alnylam Jumps on $1B RNAi Pact With Vir Biotechnology

  Alnylam and startup Vir Biotech inked a deal worth up to $1B for the development and marketing of RNAi therapies aimed at treating infectious diseases including HBV.

  October 18, 2017

   · 

  2 min read

   · 

  Alex Keown
• Business

  Former Eli Lilly Exec Emerges as the Front-Runner for Top HHS Job

  Alex Azar worked at the Department of Health and Human Services under President George W. Bush before joining drugmaker Eli Lilly.

  October 18, 2017

   · 

  1 min read
• 

  Deals

  Shire Under Pressure to Break Up the Business

  Sachem Head Capital Management is pushing for that company to break up into small entities in order to increase shareholder value.

  October 18, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Biotech Bay

  3 Under-the-Radar Bay Area Biotechs That Could Double in 2018

  Biotech stocks are generally viewed as highly volatile. Of course, along with volatility comes the possibility for huge upside rewards.

  October 18, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Policy

  Big Pharma Allegedly Funded Anti-U.S. Militia in Iraq

  The lawsuit was filed on behalf of members of the American military who were injured or killed by attacks between 2005 and 2009

  October 18, 2017

   · 

  1 min read
• 

  Business

  3 More Moderna R&D Execs Quietly Step Down

  So this year, Moderna has lost the head of its cancer division, its top lawyer, and its chief business officer.

  October 18, 2017

   · 

  1 min read
• 

  Job Trends

  Arthrex to Create 1,000 Jobs With New $74M Facility

  Arthrex will build a new state-of-the-art surgical device and implant manufacturing facility in Anderson County, S.C.

  October 18, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  FDA

  Gilead’s $12B Bet Pays Off in Two Months After the FDA Approves Kite’s Revolutionary CAR-T Therapy

  Maybe timing is everything. On Aug. 28, 2017, Gilead acquired Kite for about $11.9B.

  October 18, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Eli Lilly Strikes $1.8B mRNA R&D Pact With CureVac

  Eli Lilly has signed a collaboration deal with CureVac that could total up to $1.8B.

  October 18, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  Visterra Inks $1B Deal With This Bay Area Biotech

  Two weeks after securing more than $46M in financing, Visterra struck a deal worth up to $1B with startup Vir Biotech.

  October 18, 2017

   · 

  3 min read

   · 

  Alex Keown